SC Health invests in and builds scalable and disruptive healthcare platforms in the fast growing Asia Pacific region

ABOUT US

SC Health Corporation (“SC Health”) is a Special Purpose Acquisition Company (SPAC) incorporated in the Cayman Islands.

SC Health is currently listed on the New York Stock Exchange (NYSE). SC Health intends to acquire a target with operations or prospects in the healthcare sector in the Asia Pacific region, which may be a platform in the Asia Pacific region or a global platform with a meaningful Asia Pacific growth thesis.

BUSINESS STRATEGY

We will identify and complete an initial business combination with a company that complements the experience and skills of our management team and can benefit from our operational expertise.

We intend to:

Execute a platform-building strategy to build out investments in close alignment with the management of our acquisition target in the healthcare space
Leverage our management team’s and SINCap’s broad and deep network of relationships, unique industry expertise and proven deal-sourcing capabilities to ensure a strong and differentiated pipeline of targets
Scale the combined business platform by leveraging our management team’s and SINCap’s expertise and capabilities

Our sponsor is an affiliate of SIN Capital (“SINCap”), a Pan-Asia multi-asset professional investment firm with a differentiated investment approach centered around several key tenets:

Long-term investment horizon and close partnership with management
Building platforms in under-invested but high growth industries
Employing an ‘‘Investor-Operator’’ model focused on comprehensive operational value-add

SINCap’s strategy is focused on private investments in healthcare through its portfolio company, Fullerton Healthcare Corporation Limited; education; agri-business; advanced manufacturing; and prime real estate across gateway cities in Asia.

SINCap is led by its Chief Executive Officer, David Sin, and a management team comprising professionals with global institutional experience gained from prior roles at leading investment institutions, including Goldman Sachs and Credit Suisse. Collectively, this team possesses extensive international investment and corporate finance experience across global financial centers including New York, London, Hong Kong and Singapore.

We intend to draw upon SINCap’s infrastructure, personnel, network and relationships, which we believe will provide us with an advantage in identifying, sourcing, negotiating and executing an initial business combination in the healthcare sector in the Asia Pacific region.